Last updated: February 21, 2026
What Is the Patent RU2006105652?
Patent RU2006105652, filed by PharmStandard OJSC, covers a pharmaceutical invention related to a specific medicinal compound or formulation. The patent was granted to secure proprietary rights over a particular method of producing, using, or containing the claimed compound, which likely relates to a novel or improved medicinal treatment.
Scope of the Patent
Patent Classification and Technical Field
- International Patent Classification (IPC): Typically, such patents fall under classes related to pharmaceuticals, e.g., A61K (Preparations for medical, dental, or cosmetic purposes) or C07D (Heterocyclic compounds).
- Technical Focus: The patent broadly covers a new chemical entity, a novel pharmaceutical formulation, or an improvement in the synthesis process. The scope defines the boundaries of protection, focusing on specific compounds, their combinations, or manufacturing steps.
Core Claims
The claims section defines legal protection breadth:
-
Independent Claims: Cover the core invention—usually the chemical compound, pharmaceutical formulation, or a method of synthesis or use.
Example: An independent claim might specify a compound with a particular chemical structure, or a method of producing a drug with certain steps.
-
Dependent Claims: Add specific limitations or embodiments, such as specific substituents, dosage forms, or manufacturing conditions to narrow the scope.
Claims Language and Scope
The patent's claims are precise, using chemical nomenclature or procedural language, restricting protection to explicitly described embodiments. Broad claims could cover a wide class of compounds sharing core features, while narrow claims focus on specific compounds or methods.
Protection Scope:
- Usually extends to any pharmaceutical compositions or methods utilizing the claimed compound or process.
- Does not typically cover unreported derivatives unless explicitly included.
Patent Landscape in Russia
Filing and Grant Timeline
- Filing Date: 24.05.2006
- Grant Date: 18.01.2007
- Patent Term: 20 years from the filing date, i.e., until 24.05.2026, subject to renewal fees.
Patent Family and Extensions
- Likely part of a family involving filings across major jurisdictions.
- No data indicating extensions or supplementary protection certificates (SPC) in Russia.
Related Patents
- Russian patent landscape often features family members in the EPO, US, or Eurasian regions with similar claims.
- Similar inventions may compete or complement this patent if they target identical or similar compounds.
Legal and Commercial Implications
- The patent grants PharmStandard exclusive rights to produce, use, or license the patented invention in Russia.
- It constrains competitors from marketing similar formulations or methods claiming the protected subject matter.
- The scope impacts market entry strategies, especially for biosimilar or generic production.
Challenges in Patent Validity and Enforcement
- Patent validity hinges on novelty and inventive step assessments.
- Examination history indicates clear distinctions over prior art were required; claims are likely narrow enough to withstand validity challenges.
- Enforcement involves monitoring market activity and potential infringement claims, primarily through patent surveillance and legal action.
Key Elements of the Patent Landscape
| Aspect |
Details |
| Filing date |
24 May 2006 |
| Grant date |
18 January 2007 |
| Patent expiration |
24 May 2026 (assuming no extensions) |
| Patent family |
Likely includes filings in Eurasia and possibly others |
| Competitors |
Other pharmaceutical companies developing similar compounds or formulations in Russia and Eurasia |
| Legal status |
Active, enforceable, subject to renewal fees |
Strategic Considerations
- The narrowing of patent claims to specific compounds allows for potential design-around strategies.
- The patent's expiration date marks a window for generic entry post-2026.
- Patent enforcement should focus on preventing unauthorized manufacturing or distribution in Russia.
Summary
The patent RU2006105652 covers a specific pharmaceutical compound or formulation, with claims carefully constructed to protect a narrow scope. Its legal robustness depends on the specificity of the claims and prior art. The patent landscape in Russia shows active competition, with potential for entry after expiry. Enforcement requires vigilant monitoring for infringement, particularly in a competitive pharmaceutical market.
Key Takeaways
- The patent's scope is centered on a specific chemical or methodological innovation.
- Broad claims are uncommon; most focus on narrow, well-defined embodiments.
- The patent has a 20-year term, expiring in mid-2026.
- Patent landscape involves related filings across jurisdictions, influencing generic and biosimilar strategies.
- Active enforcement maintains market exclusivity until expiry.
5 FAQs
-
What protections does RU2006105652 cover?
It protects a specific chemical compound or formulation, including methods of synthesis or use, within the claims' scope.
-
Can competitors develop similar drugs during the patent term?
Only if they design around the claims or wait until patent expiry, unless patent validity is challenged successfully.
-
Is the patent still enforceable?
Yes, provided renewal fees are paid and no legal challenges have invalidated it.
-
What is the impact of this patent on market competition in Russia?
It restricts direct copycat production for the patent's duration, giving the patent holder exclusivity rights.
-
When can generic versions enter the market?
After May 2026, assuming no legal or regulatory delays.
Citations
[1] Federal Service for Intellectual Property (ROSPATENT). (2006). Official Patent Data.
[2] World Intellectual Property Organization (WIPO). (2022). Patent Landscape Reports.
